Post-acute Myocarditis Persistent Inflammation Score (MRI + Biomarkers) Calculator

Clinical calculation support · Verify results before clinical use

Score inputs

Enter follow-up CMR and biomarker findings. Use the local laboratory and scanner-specific reference ranges when determining whether a result is elevated.

0Points
Descriptive variable; does not contribute points in this score.
Enter 0–100%.
Enter the absolute magnitude; e.g., −18% is entered as 18. Lower values indicate worse longitudinal strain.
Use the value in mg/L.
LGE persistence or progression at follow-upCompared with prior CMR, if available.
Score adds 1 point at ≥10% LV mass.
Septal LGE presentAs assessed on CMR.
T2 mapping or T2-weighted edema elevatedDetermine using validated local reference limits and image interpretation.
Native T1 or ECV elevatedUse scanner- and sequence-specific reference ranges.
Persistent hs-cTn above the 99th percentile for ≥4 weeksBased on the assay-specific 99th percentile upper reference limit.
NT-proBNP above age-adjusted thresholdUse the relevant clinical context and laboratory threshold.
—Points
Exploratory composite score
Complete all fields
The score will be calculated when all required inputs are completed.
Important limitation: This is a pragmatic, non-validated composite score. Its point weights and cut-offs have not been established as a validated diagnostic or prognostic model. The category must not be interpreted as a calibrated probability of active inflammation or adverse events, and must not independently determine treatment.
ParameterEntered valuePoint rule in this calculator
Complete all required fields to display the calculation.

How this score is calculated

This calculator retains the point rules from the supplied source code for transparency and continuity. These weights were assembled pragmatically from published risk signals; they are not a validated model and should not be used to estimate an individual patient's absolute risk.

FindingRulePoints
LGE persistence/progressionYes+2
Septal LGEPresent+1
LGE extent≥10% LV mass+1
T2 edemaElevated+1
Native T1 or ECVElevated+1
LVEF<50%: +2; 50 to <55%: +10–2
Absolute GLS<14%: +2; 14 to <16%: +10–2
Persistent hs-cTnYes+1
NT-proBNP above thresholdYes+1
CRP≥5 mg/L+1

Interpretation of the original score bands

Original bands: 0–2 (Low), 3–4 (Intermediate), and ≥5 (High). These are retained as descriptive bands only; they have not been externally validated. The month since onset is reported for context and does not add points.

Clinical context

CMR findings must be interpreted in context. LGE may persist after myocardial inflammation has resolved and can reflect residual injury or fibrosis. T2-based assessment may be more informative for ongoing edema, but interpretation depends on image quality, technique, scanner, and reference values. Biomarkers and ventricular function complement—not replace—clinical assessment.

Evidence and references

Di Lisi D, et al. Myocarditis prognostic score: a new risk assessment tool in patients with myocarditis.European Heart Journal. 2024;45(Suppl 1):ehae666.159. Conference abstract; do not assume this calculator reproduces or validates the published score. DOI: 10.1093/eurheartj/ehae666.159
Eichhorn C, Greulich S, Bucciarelli-Ducci C, et al. Multiparametric Cardiovascular Magnetic Resonance Approach in Diagnosing, Monitoring, and Prognostication of Myocarditis.JACC: Cardiovascular Imaging. 2022;15(7):1325–1338. Review of multiparametric CMR and limitations in diagnosis, monitoring, and prognostication. DOI: 10.1016/j.jcmg.2021.11.017 · PMID: 35592889.
Brendel JM, et al. Multiparametric Cardiac Magnetic Resonance Imaging to Discriminate Endomyocardial Biopsy-Proven Chronic Myocarditis From Healed Myocarditis.JACC: Cardiovascular Imaging. 2024. Prospective single-centre study using biopsy as reference standard; supports assessment of multiparametric CMR, but does not validate the composite score on this page. PubMed: 39115501.
Clinical disclaimer: For educational and structured-reporting support only. This composite score is not a validated diagnostic, treatment-selection, or prognostic instrument. Do not diagnose persistent active myocarditis or change therapy based on this score alone. Integrate symptoms, ECG, serial biomarkers, echocardiography, CMR interpretation, differential diagnoses, and specialist assessment; consider endomyocardial biopsy when clinically indicated.